![[1(1S,2R),5(S)]-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-[2-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperazinyl]-2-(phenylmethyl)-D-erythro-pentonamide](https://img.chemicalbook.com/CAS/GIF/150323-38-9.gif)
LN-473629
[1(1S,2R),5(S)]-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-[2-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperazinyl]-2-(phenylmethyl)-D-erythro-pentonamide , 96% , 150323-38-9
Update time: 2023-04-23
PRODUCT Properties
| Melting point: | >140°C (dec.) |
| Density | 1.22 |
| storage temp. | Refrigerator |
| solubility | Methanol |
| form | Solid |
| color | Light Brown |
Description and Uses
An Intermediate in the preparation of Indinavir and also a metabolite of Indinavir. It is a COVID19-related research product.
